ย
The Europe stem cell therapy market was valued at US$ 446.75 million in 2022 and is projected to reach US$ 1,209.01 million by 2028; it is expected to grow at a CAGR of 18.0% from 2022 to 2028.
ย
Growing Prevalence of Cancer is Driving the Europe Stem Cell Therapy Market
Cancer is one of the leading causes of mortality across the world, and the disease is profoundly affecting the quality of life.
๐ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐
๐๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028473
The National Cancer Institute report also states that stem cell transplants assist in the restoration of blood-forming cells among cancer patients undergoing chemotherapy or radiation therapy. Blood-forming stem cells are important as they facilitate the growth of different types of blood cells, such as white blood cells (WBCs), red blood cells (RBCs), and platelets. The stem cell transplants do not function directly against cancer; instead, they help recover the body's ability to produce stem cells after treatment with high doses of radiation therapy, chemotherapy, or both. Thus, an increase in the demand for advanced cancer treatment is driving the growth of the Europe Stem Cell Therapy Market.
๐๐
๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/europe-stem-cell-therapy-market
ย
๐๐ก๐ ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
MEDIPOST
BioTime, Inc.
Mesoblast Limited
TiGenix NV
NuVasive Inc
Holostem Terapie Avanzate Srl
Market Segmentation and Regional Dynamics
The market can be segmented based on cell source (autologous, allogeneic, induced pluripotent stem cells (iPSCs)), therapy type (adult stem cell therapy, embryonic stem cell therapy, iPSC therapy), application (neurological disorders, cardiovascular diseases, musculoskeletal disorders, wound healing, oncology, diabetes, others), and end-user (hospitals, specialty clinics, research institutes).
Geographically, the market is primarily concentrated in Western Europe, with Germany, the UK, France, Italy, and Spain leading the way. However, Eastern European countries are also witnessing increasing interest and investment in stem cell therapies.
Key Drivers of Market Growth
Rising Prevalence of Chronic Diseases: Europe faces a significant burden of chronic diseases such as cardiovascular diseases, neurological disorders, and diabetes. Stem cell therapies offer promising avenues for treating these conditions, driving market demand.
Aging Population: Europe has an aging population, which is more susceptible to age-related diseases. Stem cell therapies hold potential for addressing these conditions, contributing to improved quality of life.
Increasing Awareness and Acceptance: Public awareness regarding the potential benefits of stem cell therapies is growing. This, combined with positive clinical trial outcomes and patient success stories, is fostering greater acceptance of these treatments.
Technological Advancements: Continuous advancements in stem cell research, including iPSC technology, gene editing, and tissue engineering, are expanding the scope of applications for stem cell therapies.
Robust Research and Development Activities: European countries have a strong research base, with numerous universities, research institutes, and companies engaged in stem cell research. Government funding and private investments are supporting these activities.
Favorable Regulatory Landscape (in some regions): Certain European countries have established regulatory frameworks for stem cell therapies, facilitating clinical trials and commercialization. However, regulations remain varied across the region, creating challenges for market harmonization.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
๐๐ฎ๐ญ๐ก๐จ๐ซโ๐ฌ ๐๐ข๐จ:
๐๐ค๐๐ฌ๐ก๐ ๐๐ก๐๐ซ๐ ๐
๐๐๐ง๐ข๐จ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ฑ๐ฉ๐๐ซ๐ญ